Cholesterol absorption inhibitors (Formulary)

EZETIMIBE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 10mg

Dosage:

Ezetimibe may be considered in combination with a statin for patients who have failed to reach target cholesterol levels despite treatment with titrated/optimised statins alone. It may also be considered as monotherapy where statins are inappropriate or poorly tolerated. 

See SMC advice 61/03.

BEMPEDOIC ACID WITH EZETIMIBE

Important: Therapy notes

  • It is more cost effective to prescribe the combination product than each product separately.

Important: Formulation and dosage details

Formulation:

Tablets 180mg/10mg tablets (Nustendi®) (specialist initiation only)

Dosage:

See SMC advice 2406.

Editorial Information

Last reviewed: 24/06/2021

Document Id: F050